Natco Pharma Ltd News

Nifty Pharma index rallies 2% in weak market;Ipca, Dr Reddy's gain up to 6%

At 02:37 pm; Nifty Pharma, the sole gainer among sectoral indices, was up 1.8 per cent, as compared to 1 per cent decline in the Nifty 50.

Natco Pharma Q2FY25 results: PAT jumps 83% to Rs 676 cr on robust sales

Natco Pharma on Tuesday said its consolidated net profit jumped 83 per cent on-year to Rs 676 crore in the September 2024 quarter, aided by robust sales. The drug maker reported a net profit of Rs 369 crore in the July-September period of last fiscal. Revenue from operations rose to Rs 1,371 crore as compared with Rs 1,031 crore in the year-ago period, the company said in a regulatory filing. "The company has shown continued strong growth during the second quarter driven by exports formulation business and stable domestic pharmaceutical business," it stated. The company said its board has declared a second interim dividend of Rs 1.5 per equity share of Rs 2 each for financial year 2024-25. Shares of the drug firm ended 0.19 per cent down at Rs 1,393.15 apiece on the BSE.

Here's why Natco Pharma share price gained over 4% on October 7; details

Natco Pharma share rose after the company announced that Mylan Pharmaceuticals Inc & Novo Nordisk have reached a settlement of the US patent litigation related to generic Ozempic (Semaglutide)

Natco Pharma shares hit all time high, extend gain for second day; details

The Natco Pharma share price has surged nearly 20 per cent in the last one month, and by 92 per cent year to date

Natco Pharma stock rises 3% after subsidiary invests $8 mn in biotech firm

Natco Pharma share price rose after the company on Wednesday announced that its wholly owned Canadian subsidiary, NATCO Pharma Inc, has made an investment of $8 million in eGenesis

Natco Pharma rises 4% after filing ANDA for generic lung cancer drug

Natco Pharma is the first company to have filed a substantially complete ANDA for a generic cancer drug